足ることを知らず

Data Science, global business, management and MBA

M&A

Day 149 in MIT Sloan Fellows Class 2023, M&A 13 "SPAC"

A Special Purpose Acquisition Company (SPAC) is a type of investment vehicle that allows public market investors to participate in the initial public offering (IPO) and merger and acquisition (M&A) processes. SPACs are essentially shell co…

Day 143 in MIT Sloan Fellows Class 2023, M&A 12 "Company Selling Process"

www.hbs.edu We wrap up our journey to learn M&A process with reviewing the whole process by looking at small and middle size deals. When you sell your company to typical buyers such as strategic buyers and PE firms, you need to consider th…

Day 139 in MIT Sloan Fellows Class 2023, M&A 11 "Public to Private"

Outback LBO deal by Bain Capital In 2007, Bain Capital partnered with Catterton Partners and other investors to execute a leveraged buyout (LBO) of OSI Restaurant Partners, the parent company of Outback Steakhouse. OSI Restaurant Partners …

Day 136 MIT Sloan Fellows Class 2023, M&A and PE 10 "Technical M&A by PE"

How we should evaluate technical capability in M&A from PE perspective? Is there enough room to improve? How was the price? Over-pricing or underestimated? We reviewed three acquistion targets, Seagate-Hard drive manufacturers, McAfee, and…

Day 134 MIT Sloan Fellows Class 2023, M&A and PE 9 "LBO modeling"

LBO modeling Leveraged Buyout (LBO) modeling is a key tool used by private equity (PE) firms to evaluate the potential acquisition of a company using a significant amount of debt. The goal is to achieve high returns by using leverage, impr…

Day 128 MIT Sloan Fellows Class 2023, M&A and PE 8 "Private Equity"

Fund setup Private Equity is a group of investors pools their money together to purchase ownership stakes in companies that are not publicly traded (i.e., not listed on a stock exchange). The group of investors is typically organized as a …

Day 126 MIT Sloan Fellows Class 2023, M&A and PE 7 "Active investors and strategic discrepancy"

Valeant, Allergan and Ackman: overview from ChatGPT www.reuters.com In 2014, Valeant Pharmaceuticals International made an unsolicited bid to acquire Allergan, a company specializing in aesthetic medicine, for $47 billion. Allergan rejecte…

Day 123 in MIT Sloan Fellows Class 2023, M&A and PE 6 "Poison pill"

Hostile take over Why We Need More Hostile Takeovers In the 1980s, hostile takeovers were not a rare strategy, and many activists tried to take over inefficient companies. And then, they fired board members and cut down the majority of cos…